Brunei EMS Funding: EMAS 991, Ministry of Health and Device Procurement
Brunei EMS Funding: EMAS 991, Ministry of Health and Device Procurement
Research snapshot · 14 August 2026. Brunei is a small but relatively high-income institutional medical technology market. Emergency access, possible patient charges, public service financing and central medical-device procurement must be examined separately.
Emergency Medical Ambulance Service
Brunei’s Ministry of Health operates the public Emergency Medical Ambulance Service (EMAS), reachable through the emergency number 991. EMAS is thus the identifiable public prehospital emergency-care route. A reliable, generally applicable and current patient charge per EMAS deployment was not found in the official sources, so no tariff is inferred.
Brunei Ministry of Health – EMAS 991.
Procurement is the crucial funding channel
Medical-device procurement can be traced directly to the Ministry of Health. A current MOH tender dated 1 July 2026, for example, seeks two defibrillators for the Emergency Medical Ambulance Service. This provides concrete evidence of a central purchasing route for prehospital medical technology.
Potential AIRCHILL pathway: MOH tenders and procurement, equipment for the EMAS fleet, clinical/operational pilots and hospital/EMS evaluation programmes. No separate case-based reimbursement code for AIRCHILL is assumed.
MOH Tender KK/138/2026/HTD – EMAS defibrillators.
Remaining data gap
The absence of an official general EMAS patient charge is not an invitation to estimate one. Pending a sourced fee schedule, patient/provider payment remains DYNAMIC / NOT PUBLIC. For an institutional medical-device market, documented public tenders are a stronger basis for commercial planning than an assumed ambulance transport tariff.
Interpretation limit: Public EMAS operation and MOH procurement do not prove that services are free for every patient group or that AIRCHILL has a dedicated reimbursement pathway.
English working translation of the German original. Source figures retain their original 2026 research-snapshot dates. The publication does not establish any AIRCHILL-specific reimbursement or device authorization. Market-data source review pending.